Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: Role of tight junction proteins and matrix metalloproteinase-9

Brain Research

Volumn 1411, Issue , 2011, Pages 28-40

  Martins, Tânia ^a   Baptista, Sofia ^a   Gonçalves, Joana ^a   Leal, Ermelindo ^b   Milhazes, Nuno ^c   Borges, Fernanda ^d   Ribeiro, Carlos F ^a   Quintela, Oscar ^e   Lendoiro, Elena ^e   López Rivadulla, Manuel ^e   Ambrósio, António F ^a   Silva, Ana P ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Institute of Health Sciences North   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Blood brain barrier; Hippocampus; Matrix metalloproteinase 9; Methamphetamine; Tight junction

Indexed keywords

BATIMASTAT; CLAUDIN 5; GELATINASE B; METHAMPHETAMINE; OCCLUDIN; PROTEIN ZO1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIGHT JUNCTION;

AMPHETAMINE; ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; EVANS BLUE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PERMEABILITY; PREFRONTAL CORTEX; TANDEM MASS SPECTROMETRY; TIGHT JUNCTIONS;

MUS;

EID: 80052037570     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.07.013     Document Type: Article

References (70)

1. S.M. Agrawal, L. Lau, and V.W. Yong MMPs in the central nervous system: where the good guys go bad Semin. Cell Dev. Biol. 19 2008 42 51 Review (Pubitemid 350235982)
2. S. Aijaz, M.S. Balda, and K. Matter Tight junctions: molecular architecture and function Int. Rev. Cytol. 248 2006 261 298 Review (Pubitemid 43238173)
3. M. Asahi, K. Asahi, J.C. Jung, G.J. del Zoppo, M.E. Fini, and E.H. Lo Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94 J. Cereb. Blood Flow Metab. 20 2000 1681 1689
4. P. Ballabh, A. Braun, and M. Nedergaard The blood-brain barrier: an overview: structure, regulation, and clinical implications Neurobiol. Dis. 16 2004 1 13 Review (Pubitemid 38569790)
5. A. Banerjee, X. Zhang, K.R. Manda, W.A. Banks, and N. Ercal HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide Free Radic. Biol. Med. 48 2010 1388 1398
6. G. Bazzoni, and E. Dejana Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis Physiol. Rev. 84 2004 869 901 Review (Pubitemid 38823769)
7. C. Bojarski, J. Weiske, T. Schoneberg, W. Schroder, J. Mankertz, J.D. Schulzke, P. Florian, M. Fromm, R. Tauber, and O. Huber The specific fates of tight junction proteins in apoptotic epithelial cells J. Cell Sci. 117 2004 2097 2107 (Pubitemid 38745142)
8. J.F. Bowyer, and S. Ali High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus Synapse 60 2006 521 532 (Pubitemid 44537085)
9. J.F. Bowyer, B. Robinson, S. Ali, and L.C. Schmued Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure Synapse 62 2008 193 204 (Pubitemid 351186400)
10. P.M. Carvey, C.H. Zhao, B. Hendey, H. Lum, J. Trachtenberg, B.S. Desai, J. Snyder, Y.G. Zhu, and Z.D. Ling 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability Eur. J. Neurosci. 22 2005 1158 1168 (Pubitemid 41395380)
11. J. Correale, and A. Villa The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting Autoimmunity 40 2007 148 160 Review
12. K. Conant, C. St Hillaire, C. Anderson, D. Galey, J. Wang, and A. Nath Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases J. Neurovirol. 10 2004 21 28 (Pubitemid 38325106)
13. R. de la Torre, M. Farre, M. Navarro, R. Pacifici, P. Zuccaro, and S. Pichini Clinical pharmacokinetics of amphetamine and related substances: monitoring in conventional and non-conventional matrices Clin. Pharmacokinet. 43 2004 157 185 Review (Pubitemid 38294379)
14. H.E. de Vries, M.C. Blom-Roosemalen, M. van Oosten, A.G. de Boer, T.J. van Berkel, D.D. Breimer, and J. Kuiper The influence of cytokines on the integrity of the blood-brain barrier in vitro J. Neuroimmunol. 64 1996 37 43 (Pubitemid 26052072)
15. X. Deng, Y. Wang, J. Chou, and J.L. Cadet Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method Brain Res. Mol. Brain Res. 93 2001 64 69 (Pubitemid 32786903)
16. J.B. Dietrich Alteration of blood-brain barrier function by methamphetamine and cocaine Cell Tissue Res. 336 2009 385 392 Review
17. M. Drozdzik, M. Bialecka, K. Mysliwiec, K. Honczarenko, J. Stankiewicz, and Z. Sych Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease Pharmacogenetics 13 2003 259 263 (Pubitemid 36583992)
18. C. Forster Tight junctions and the modulation of barrier function in disease Histochem. Cell Biol. 130 2008 55 70 Review
19. M. Fujimura, Y. Gasche, Y. Morita-Fujimura, J. Massengale, M. Kawase, and P.H. Chan Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion Brain Res. 842 1999 92 100 (Pubitemid 29447856)
20. C.K. Glass, K. Saijo, B. Winner, M.C. Marchetto, and F.H. Gage Mechanisms underlying inflammation in neurodegeneration Cell 140 2010 918 934 Review
21. S.M. Gloor, A. Weber, N. Adachi, and K. Frei Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells Biochem. Biophys. Res. Commun. 239 1997 804 809 (Pubitemid 27504183)
22. J. Gonçalves, S. Baptista, T. Martins, N. Milhazes, F. Borges, C.F. Ribeiro, J.O. Malva, and A.P. Silva Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin Eur. J. Neurosci. 31 2010 315 326
23. K.J. Gurney, E.Y. Estrada, and G.A. Rosenberg Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation Neurobiol. Dis. 23 2006 87 96 (Pubitemid 43903633)
24. K. Jian Liu, and G.A. Rosenberg Matrix metalloproteinases and free radicals in cerebral ischemia Free Radic. Biol. Med. 39 2005 71 80 Review (Pubitemid 40733117)
25. G.D. Kanmogne, K. Schall, J. Leibhart, B. Knipe, H.E. Gendelman, and Y. Persidsky HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis J. Cereb. Blood Flow Metab. 27 2007 123 134 (Pubitemid 46006590)
26. R.E. Kast Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma J. Neurooncol. 94 2009 163 167 Review
27. R.E. Kast, and D. Focosi Three paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinib Transl. Oncol. 3 2010 13 15
28. B. Keogh, B.J. Sheahan, G.J. Atkins, and K.H. Mills Inhibition of matrix metalloproteinases ameliorates blood-brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection Vet. Immunol. Immunopathol. 94 2003 185 190 (Pubitemid 37297423)
29. E.A. Kiyatkin, P.L. Brown, and H.S. Sharma Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia Eur. J. Neurosci. 26 2007 1242 1253 (Pubitemid 47346759)
30. B. Ladenheim, I.N. Krasnova, X. Deng, J.M. Oyler, A. Polettini, T.H. Moran, M.A. Huestis, and J.L. Cadet Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6 Mol. Pharmacol. 58 2000 1247 1256
31. Y. Liu, S. Brown, J. Shaikh, J.A. Fishback, and R.R. Matsumoto Relationship between methamphetamine exposure and matrix metalloproteinase 9 expression Neuroreport 19 2008 1407 1409
32. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat. Rev. Neurosci. 4 2003 399 415 Review (Pubitemid 37280178)
33. C. Lohmann, M. Krischke, J. Wegener, and H.J. Galla Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways Brain Res. 995 2004 184 196 (Pubitemid 37522019)
34. S.D. Mahajan, R. Aalinkeel, D.E. Sykes, J.L. Reynolds, B. Bindukumar, A. Adal, M. Qi, J. Toh, G. Xu, P.N. Prasad, and S.A. Schwartz Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse Brain Res. 1203 2008 133 148
35. A. Manaenko, H. Chen, J. Kammer, J.H. Zhang, and J. Tang Comparison Evans Blue injection routes: intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model J. Neurosci. Methods 195 2011 206 210
36. S. McQuaid, P. Cunnea, J. McMahon, and U. Fitzgerald The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis Biochem. Soc. Trans. 37 2009 329 331 Review
37. W.P. Melega, A.E. Williams, D.A. Schmitz, E.W. DiStefano, and A.K. Cho Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal J. Pharmacol. Exp. Ther. 274 1995 90 96
38. H. Mizoguchi, K. Yamada, A. Mouri, M. Niwa, T. Mizuno, Y. Noda, A. Nitta, S. Itohara, Y. Banno, and T. Nabeshima Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release J. Neurochem. 102 2007 1548 1560 (Pubitemid 47256194)
39. H. Mizoguchi, K. Yamada, M. Niwa, A. Mouri, T. Mizuno, Y. Noda, A. Nitta, S. Itohara, Y. Banno, and T. Nabeshima Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice J. Neurochem. 100 2007 1579 1588 (Pubitemid 46376198)
40. M. Narita, M. Suzuki, N. Kuzumaki, M. Miyatake, and T. Suzuki Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine Ann. N. Y. Acad. Sci. 1141 2008 96 104 Review
41. Y. Persidsky, S.H. Ramirez, J. Haorah, and G.D. Kanmogne Blood-brain barrier: structural components and function under physiologic and pathologic conditions J. Neuroimmune Pharmacol. 1 2006 223 236 Review (Pubitemid 44244128)
42. M.A. Petty, and E.H. Lo Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation Prog. Neurobiol. 68 2002 311 323 Review (Pubitemid 36071509)
43. D. Pubill, A.M. Canudas, M. Pallas, A. Camins, J. Camarasa, and E. Escubedo Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity Naunyn Schmiedebergs Arch. Pharmacol. 367 2003 490 499 (Pubitemid 36718300)
44. P.B. Pun, J. Lu, and S. Moochhala Involvement of ROS in BBB dysfunction Free Radic. Res. 43 2009 348 364 Review
45. M.S. Quinton, and B.K. Yamamoto Causes and consequences of methamphetamine and MDMA toxicity AAPS J. 8 2006 E337 E347 Review (Pubitemid 43790783)
46. S.H. Ramirez, R. Potula, S. Fan, T. Eidem, A. Papugani, N. Reichenbach, H. Dykstra, B.B. Weksler, I.A. Romero, P.O. Couraud, and Y. Persidsky Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells J. Cereb. Blood Flow Metab. 29 2009 1933 1945
47. I.A. Romero, K. Radewicz, E. Jubin, C.C. Michel, J. Greenwood, P.O. Couraud, and P. Adamson Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells Neurosci. Lett. 344 2003 112 116 (Pubitemid 36628019)
48. G.A. Rosenberg Matrix metalloproteinases in neuroinflammation Glia 39 2002 279 291 Review
49. G.A. Rosenberg, E.Y. Estrada, and J.E. Dencoff Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain Stroke 29 1998 2189 2195 (Pubitemid 28443538)
50. K.E. Sandoval, and K.A. Witt Blood-brain barrier tight junction permeability and ischemic stroke Neurobiol. Dis. 32 2008 200 219 Review
51. H.S. Sharma, and S.F. Ali Alterations in blood-brain barrier function by morphine and methamphetamine Ann. N. Y. Acad. Sci. 1074 2006 198 224 (Pubitemid 44532825)
52. A.P. Silva, T. Martins, Baptista S., J. Gonçalves, F. Agasse, and J.O. Malva Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier Curr. Drug Abuse Rev. 3 2010 239 254 Review
53. P.F. Simões, A.P. Silva, F.C. Pereira, E. Marques, S. Grade, N. Milhazes, F. Borges, C.F. Ribeiro, and T.R. Macedo Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory Neuroscience 150 2007 433 441 (Pubitemid 350214497)
54. P. Svedin, H. Hagberg, K. Savman, C. Zhu, and C. Mallard Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia J. Neurosci. 27 2007 1511 1518 (Pubitemid 46280068)
55. A. Szklarczyk, J. Lapinska, M. Rylski, R.D. McKay, and L. Kaczmarek Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus J. Neurosci. 22 2002 920 930 (Pubitemid 34141772)
56. V.E. Thiel, and K.L. Audus Nitric oxide and blood-brain barrier integrity Antioxid. Redox. Signal. 3 2001 273 278 Review (Pubitemid 32473342)
57. D.M. Thomas, J. Dowgiert, T.J. Geddes, D. Francescutti-Verbeem, X. Liu, and D.M. Kuhn Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines Neurosci. Lett. 367 2004 349 354 (Pubitemid 39178611)
58. D.M. Thomas, and D.M. Kuhn Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine J. Neurochem. 92 2005 790 797 (Pubitemid 40229550)
59. P.M. Thompson, K.M. Hayashi, S.L. Simon, J.A. Geaga, M.S. Hong, Y. Sui, J.Y. Lee, A.W. Toga, W. Ling, and E.D. London Structural abnormalities in the brains of human subjects who use methamphetamine J. Neurosci. 24 2004 6028 6036 (Pubitemid 38859399)
60. M.C. Tobias, J. O'Neill, M. Hudkins, G. Bartzokis, A.C. Dean, and E.D. London White-matter abnormalities in brain during early abstinence from methamphetamine abuse Psychopharmacology (Berl) 209 2010 13 24
61. M. Toborek, Y.W. Lee, G. Flora, H. Pu, I.E. Andras, E. Wylegala, B. Hennig, and A. Nath Mechanisms of the blood-brain barrier disruption in HIV-1 infection Cell. Mol. Neurobiol. 25 2005 181 199 Review (Pubitemid 40558590)
62. A.R. Tunkel, and W.M. Scheld Pathogenesis and pathophysiology of bacterial meningitis Annu. Rev. Med. 44 1993 103 120 Review (Pubitemid 23117852)
63. M. Wachtel, K. Frei, E. Ehler, A. Fontana, K. Winterhalter, and S.M. Gloor Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition J. Cell Sci. 112 Pt 23 1999 4347 4356 (Pubitemid 30122026)
64. H. Wolburg, S. Noell, A. Mack, K. Wolburg-Buchholz, and P. Fallier-Becker Brain endothelial cells and the glio-vascular complex Cell Tissue Res. 335 2009 75 96 Review
65. B.K. Yamamoto, A. Moszczynska, and G.A. Gudelsky Amphetamine toxicities: classical and emerging mechanisms Ann. N. Y. Acad. Sci. 1187 2010 101 121 Review
66. B.K. Yamamoto, and J. Raudensky The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse J. Neuroimmune Pharmacol. 3 2008 203 217 Review
67. Y. Yang, E.Y. Estrada, J.F. Thompson, W. Liu, and G.A. Rosenberg Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat J. Cereb. Blood Flow Metab. 27 2007 697 709 (Pubitemid 46474608)
68. V.W. Yong Metalloproteinases: mediators of pathology and regeneration in the CNS Nat. Rev. Neurosci. 6 2005 931 944 Review (Pubitemid 41753087)
69. C. Zhao, Z. Ling, M.B. Newman, A. Bhatia, and P.M. Carvey TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice Neurobiol. Dis. 26 2007 36 46 (Pubitemid 46437443)
70. B.V. Zlokovic The blood-brain barrier in health and chronic neurodegenerative disorders Neuron 57 2008 178 201 Review